Inspire Medical Systems, Inc. to Present at the 10th Annual SVB Leerink Global Healthcare Conference
MINNEAPOLIS, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on...
Day: February 11, 2021
X4 Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host a Conference Call and Webcast on March 4, 2021
BOSTON, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development...
Biogen Announces the Expiration Date Results of Its Private Exchange Offer
CAMBRIDGE, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (“Biogen”) (Nasdaq: BIIB) today announced the expiration date results of...
WellDyne Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care
New PrismRA® blood test enables providers to identify optimal approach to rheumatoid arthritis treatmentWALTHAM, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE)...
aTyr Pharma Announces New tRNA Synthetase Discovery Programs
Advancement of selected AARS and DARS fragments primarily targeting cancer Programs will accelerate discoveries initially focusing on natural killer (NK)...
Intercept to Announce Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021
NEW YORK, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and...
electroCore Announces Completion of Enrollment in SAVIOR-1 Study of Non-Invasive Vagus Nerve Stimulation (nVNS) in COVID-19 Patients Exhibiting Respiratory Symptoms
ROCKAWAY, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the...
Cidara Therapeutics to Present New Data for Rezafungin and Influenza AVCs at the 21st ICHS Symposium
SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed...
Aleafia Health Launches Sunday Market™ House of Brands
The Sunday Market house of brands Aleafia Health Inc. TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX:...
Neuronetics Announces Strategic Leadership Promotions to Support Future Growth
Elevated roles announced for executive team members Steve Furlong, Greg Harper and Kara ThorntonMALVERN, Pa., Feb. 11, 2021 (GLOBE NEWSWIRE)...
Genocea Provides Fourth Quarter 2020 Corporate Update
GEN-011 and GEN-009 clinical trials continue to advance ATLASTMstimulatory antigen and inhibitory antigen (InhibigenTM) identification profiled in Cancer Discovery Announcing...
Antios Therapeutics Appoints Patrick T. Higgins to Board of Directors
Former biopharmaceutical executive has been at the forefront of developing treatments for infectious diseases of the liver including HBV and...
InflaRx Announces Presentation of New C5a and Vilobelimab (IFX-1) Data from Phase IIB SHINE Study at the 2021 Virtual European Hidradenitis Suppurativa Foundation Conference
Significantly elevated baseline C5a levels occur in hidradenitis suppurativa (HS) patientsVilobelimab dose-dependently suppresses C5a levels over time accompanied by the...
Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer
Molecular Templates to receive $70 million upfront payment with potential for additional milestone and royalty payments on future salesAUSTIN, Texas,...
Eve & Co Completes First Shipment of Dried Flower Products to the Province of New Brunswick
STRATHROY, Ontario, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE;...
Biogen and LabCentral Award Two Golden Tickets to Local and Innovative Science Startups
Golden Tickets winners Bolden Therapeutics and Seranova Bio will have access to a state-of-the-art lab facilities at LabCentral with mentorship...
Plus Therapeutics to Participate in BIO CEO & Investor Digital Conference
Buzz of BIO Public Therapeutic Biotech Winner AUSTIN, Texas, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the...
MacroGenics Announces Achievement of $10 Million Milestone Related to Retifanlimab Collaboration with Incyte
ROCKVILLE, MD, Feb. 11, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing...
Monopar Announces Publication Demonstrating Potential Utility of MNPR-101 as an Imaging Agent to Improve Surgical Outcomes in Bladder Cancer
WILMETTE, Ill., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed...
Modern Health Gains Unicorn Status After $74 Million Series D at $1.17 Billion Valuation
Led by Founders Fund, Funding Round Brings Total Investment to Over $172 Million To Support Accelerated Growth & Rising Demand...